Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Secukinumab for Juvenile Arthritis
Recruiting2 awardsPhase 3
Portland, Oregon
This trial is investigating whether secukinumab is effective and safe in treating two subtypes of Juvenile Idiopathic Arthritis: Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.